Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024The American Journal of Gastroenterology

Randomized Controlled Trial of Intravenous Ferric Carboxymaltose vs Oral Iron to Treat Iron Deficiency Anemia After Variceal Bleed in Patients With Cirrhosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMohammad TabishSASamagra AgarwalSGSrikanth Gopi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tabish et al. (2024) studied this question.

synapsesocial.com/papers/68e72b9db6db6435876a57e2https://doi.org/10.14309/ajg.0000000000002775
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment2017 · 118 citations
  2. 2Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP)2016 · 154 citations
  3. 3Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement2009 · 145 citations
  4. 4Severe Hypophosphatemia After Intravenous Administration of Iron Carboxymaltose in a Stable Renal Transplant Recipient2010 · 37 citations
  5. 5Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease2019 · 94 citations